Please click here to view the 2019 Journal of Drug Assessment.

To view abstract posters, please click on the abstract titles below.

patiromer and maintenance of RAASi Therapy in Hyperkalemic Medicare Patients

Authors: Desai NR, Rowan CG, Alvarez PJ, FOgl

Psoriasis Patients utilizing secukinumab, ixekizumab or brodalumab – comparisons to prior biologic medication adherence levels, reasons for switching, and reported changes in disease symptoms

Authors: Baiano R, Staskon F, Miller R

The impact of an integrated health-system specialty pharmacy on HIV antiretrovial therapy adherence, viral suppression and CD4 Count in an Outpatient ID clinic

Authors: Barnes E, Giumenta A, Johnson M, Zhao J

Assess integrated specialty pharmacy services as a medication optimization strategy for rifaximin in hepatic encephalopathy patients

Authors: Mac E, Battershell A, Buaisha H, Nolan K

Medication adherence and graft survival among heart transplant recipients

Author: Boghani S, Kirkham H, Witt EA, Hira N, Cherikh WS, Wilk AR, Maghirang J, Pietradoni G

Medication adherence and graft survival among kidney transplant recipients

Author: Boghani S, Kirkham H, Witt EA, Hira N, Cherikh WS, Wilk AR, Maghirang J, Pietradoni G

Management of specialty drugs, specialty pharmacies, and biosimilars in the united states

Authors: Brook R, Smeeding J, Carlisle J, Sax M

United States Health plan cancer concerns in 2019

Authors: Brook R, Sax M, Carlisle J, Smeeding J

Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy

Authors: Bhusal B, Oleru K, Arikian V, Jaster R, Stranz M, Lindhorst J

Appropriate prescribing of antimetics with oral oncolytic therapy – a single center experience

Authors: Suen CT, Hughes ME, Timlin C, Cambareri C, Kriska R, Strong G, Favatella JK, Demers R, Capozzi DL

Variation in health plan specialty drug coverage: An empirical analysis

Authors: Margaretos NM, Lai RC, Panzer AD, Chambers JD

Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic

Authors: Chelewski R, Johnson K, Suckerman A, DeClercq J, Choi L, Peter M, Langone A

Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database

Authors: Farkas H, Fridman M, Supina D, Chiao J, Prusty S, Berger M

Coupling patient care management operations with technology and data platform to optimize hepatitis C therapy outcomes

Authors: Duong L, Malachowski M, Tran K

Clinical impact of a pharmacist interventions on improving outcomes in patients receiving immune globulin therapy in a home setting

Authors: DiStefano J, Vaughan L

Determining Specialty pharmacy FTEs (Full-Time equivalents) needed in a clinical practice

Authors: Holton J, Favatella J, Capozzi D, Demers R

Real-World assessment of an integrated clinical model on oral hepatitis C therapy at Southern ohio medical center

Authors: Ferraro R, Quillen S, Phillips R, Newman B

Impact of ambulatory clinical pharmacists interventions on outcomes in the HIV population

Authors: Foltanski L

Development of a palivizumab specialty pharmacy management program

Authors: Harlan L, Benskin K, Gatzke C, Majors A

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks

Authors: Tyson C, Anurag R, Adams P, Haynes A, Magar R

Cost of leukopenia and neutropenia in metastatic breast cancer within last 12, 36, and 60 months using a curated disease model

Authors: Alford SH, Ng M, Meade M

Integrating high touch specialty pharmacy services within a neurology clinic to improve medication access and affordability

Author: Hickman A, Edwards K

Implementation of an Internal Check of Oral Oncolytics: A single-center, specialty pharmacy safety initiative

Author: Hughes M, Kriska R, Strong G, Chung J, Nguyen L, Rubin D, Murphy M, Favatella J, Capozzi D

Impact of specialty pharmacy taking ownership of the prior authorization process of Multiple sclerosis specialty medications to increase access to infusible disease-modifying therapy (DMT)

Authors: Whetstone M, Reichard J, Sigmon S

Impact of a specialty pharmacy benefit on rheumatoid arthritis medication adherence and functional status: a continuation study

Authors: Zande M, Wickizer M, Topp R, Faust S, Hustad C

Economic burden of hemophilia B in the US: A systematic literature review

Authors: Li N, Sawyer EK, Maruszczyk K, Slomka M, Burke T, Martin AP, O’Hara J

Impact of specialty pharmacist integration on time to medication access for pimavanserin

Authors: Livezey S, McCormick R, Shah NB, Choi L, DeClercq J, Zuckerman AD

A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib

Authors: Nix R, Looney B, Lamb C, Peter M, Zuckerman AD

Measuring the impact of integrating PGY-2 ambulatory care pharmacy residents into specialty clinics

Authors: Spencer C, Woosley M, Brenske A, O’Reilly E.

Comparison of Extended to standard half-life recombinant factor VII therapy in patients with hemophilia A on Prophylactic treatment

Authors: Koerner P, Miller R, Radi M

impact of using real – world outcomes versus clinical evidence and list prices on value assessments

Authors: Meade D, Ng M, Alford SH

Understanding purchasing patterns and product access of newly launched specialty generics

Authors: Ness S, Lucas R

Development of a specialty pharmacy productivity benchmarking model

Authors: Platt T, Shah R

Estimating the value of pharmacist interventions in a specialty pharmacy setting

Authors: Craig R, Grant K

Evaluation of a specialty pharmacy health coaching program

Authors: Simonson D, Wittenborg M, Snyder M, Wiest H, McNamara A

Impact of multidisciplinary patient education sessions on expectations and understanding of new CGRP treatments

Authors: Stewart A, Wells R, Young J, Strauss L, Wise S, Granetzke L, Kumar S, Speiser J, Guzik A, O’Connell N

Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patients

Authors: Petrosan A, Belfield K, Cohen E, DelVecchio M, Stutsky M

Impact of health-system specialty pharmacy services on medication adherence in pediatric patients with cystic fibrosis

Authors: Tao V, Papiro T, Stutsky M, DelVecchio M, Kelly SA

Correlates and barriers to medication adherence in multiple sclerosis patients and their impact on clinical outcomes

Authors: McPherson D, D’Ambrosi M, Stutsky M

A novel tool to monitor adherence to oral oncolytics: a pilot study

Authors: Sun W, Reeve R, Ouellette T, Stutsky M, De Jesus R, Huffer MJ, Mougalian SS

Patterns of on-demand medication use in patients with hereditary angioedema treated long-term with prophlactic subcutaneous C1-inhibitor

Authors: Levy DS, Chiao J, Dang J, Hood C, Supina D, Feuersenger H

Comparison of healthcare utilization among managed Medicaid individuals diagnosed with multiple sclerosis treated with emergent vs. established disease modifying therapy

Authors: Sutton B, Petrilla A, Teigland C

Impact of a high-touch, collaborative, patient-centric, hepatitis C specialty clinical program on completion of glecaprevir/pibrentasvir therapy

Authors: Swoope M, Bertram C, Krouskos R, Peeler G, Wood C

Predicting Time to Medication Access for Hematologic Malignancies: The impact of an integrated specialty pharmacy and limited distribution drug networks

Authors: Zuckerman AD, Peter ME, Starks S, Maulis M, Declerq J, Choi L, Jagasia M

2020 Abstracts and Poster Presentations Protected: 2020 Annual Meeting Presentations